Incidence and risk factors for pneumonitis in urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab: retrospective study

Luis Angel Diaz Tejada, Fabiana Alexandra Príncipe Osorio, Abdelrahman M Attia, Ivan Alexander Flores Hernandez, Emilio Jacques Villarreal, Omar Alhalabi, Matthew T Campbell, Cindy Y Jiang, Zachariah Thomas, Girish S Shroff, Mehmet Altan, Jianjun Gao, Ajay Sheshadri · 2026

Read Incidence and risk factors for pneumonitis in urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab: retrospective study by Luis Angel Diaz Tejada, Fabiana Alexandra Príncipe Osorio, Abdelrahman M Attia, Ivan Alexander Flores Hernandez, Emilio Jacques Villarreal, Omar Alhalabi, Matthew T Campbell, Cindy Y Jiang, Zachariah Thomas, Girish S Shroff, Mehmet Altan, Jianjun Gao, Ajay Sheshadri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623520.txt.

Description

Luis Angel Diaz Tejada and co-authors count lung swelling in bladder cancer patients on a paired drug cure in a 2026 study. The pair is now front-line care for spread cases, but real-world rates of this lung harm were vague. Records from one large cancer centre form the base.

Lung swelling hit about seven in a hundred patients, most often in the first few months. Past immune drug care was the sole clear risk flag, and worse cases tied to higher death risk. Twelve patients were re-tried on the cure, with no clear return of the lung harm in that small set.

Catalog record

CREATORLuis Angel Diaz Tejada, Fabiana Alexandra Príncipe Osorio, Abdelrahman M Attia, Ivan Alexander Flores Hernandez, Emilio Jacques Villarreal, Omar Alhalabi, Matthew T Campbell, Cindy Y Jiang, Zachariah Thomas, Girish S Shroff, Mehmet Altan, Jianjun Gao, Ajay Sheshadri
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13623520

Browse the full library · About the Tower of Babel